Patent details

EP1423364 Title: CRYSTALLINE FORMS OF ÖR-(R*,R*)Ü-2-(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-PHENYLAMINO)CARBONYLÜ-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1) (ATORVASTATIN)

Basic Information

Publication number:
EP1423364
PCT Application Number:
PCT/IB/2002/001796
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027279462
PCT Publication Number:
WO/2003/004470
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE FORMS OF ÖR-(R*,R*)Ü-2-(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-PHENYLAMINO)CARBONYLÜ-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1) (ATORVASTATIN)
French Title of Invention:
FORMES CRISTALLINES DE SEL HEMICALCIQUE (2:1) D'ACIDE ÖR-(R*,R*)Ü -2-(4-FLUOROPHENYL)-BETA,DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-(PHENYLAMINO)CARBONYL -1H-PYRROLE-1-HEPTANOIQUE (ATORVASTATINE)
German Title of Invention:
KRISTALLINE FORMEN DES CALCIUMSALZES (2:1) VON ÖR-(R*,R*)Ü-2-(4-FLUORPHENYL)-BETA, DELTA -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-(PHENYLAMINO)CARBONYLÜ-1H-PYRROL-1-HEPTANSÄURE (ATORVASTATIN)
SPC Number:

Dates

Filing date:
21/05/2002
Grant date:
04/11/2015
EP Publication Date:
04/11/2015
PCT Publication Date:
16/01/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/06/2004
EP B1 Publication Date:
04/11/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/05/2016
Expiration date:
21/05/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/05/2002
 
 

Name:
Warner-Lambert Company LLC
Address:
235 East 42nd Street, New York, NY 10017, United States (US)

Inventor

1

Name:
MORRISON Henry Grant, II
Address:
United States (US)

2

Name:
LI Zheng J., Pfizer Global Research and Develop.
Address:
United States (US)

3

Name:
VLAHOVA Petinka Ivanova
Address:
United States (US)

4

Name:
BYRN Stephen Robert
Address:
United States (US)

5

Name:
PARK Aeri
Address:
United States (US)

6

Name:
COATES David Andrew
Address:
United States (US)

7

Name:
KRZYZANIAK J. F., Pfizer Global Researchand Dev.
Address:
United States (US)

8

Name:
GUSHURST Karen Sue
Address:
United States (US)

Priority

Priority Number:
302049 P
Priority Date:
29/06/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 207/34;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages